Paxman AB (publ) (STO:PAX)
Sweden · Delayed Price · Currency is SEK 56.20
+2.20 (4.07%)
At close: Dec 30, 2025
Paxman AB Market Cap
Paxman AB has a market cap or net worth of 1.31 billion as of December 31, 2025. Its market cap has increased by 7.83% in one year.
Market Cap
1.31B
Enterprise Value
1.19B
Revenue
305.02M
Ranking
n/a
PE Ratio
239.45
Stock Price
56.20
Market Cap Chart
Since June 12, 2017, Paxman AB's market cap has increased from 174.54M to 1.31B, an increase of 649.40%. That is a compound annual growth rate of 26.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 1.31B | 4.87% |
| Dec 30, 2024 | 1.25B | 78.26% |
| Dec 29, 2023 | 699.66M | -14.62% |
| Dec 30, 2022 | 819.44M | -33.69% |
| Dec 30, 2021 | 1.24B | 203.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.91B |
| Getinge AB | 58.10B |
| Sectra AB | 48.55B |
| Camurus AB | 37.07B |
| Medicover AB | 33.06B |
| Asker Healthcare Group AB | 32.72B |
| BioArctic AB | 28.38B |
| Elekta AB | 21.47B |